(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Artemis 2 captures historic 'Earthset' photo | Space photo of the day for April 7, 2026 - 2She was the supermodel dubbed 'The Face' in the '80s. Joining OnlyFans in her 60s taught her a lot.
- 315 Outrageous Cosplay Outfits That Will Blow You Away
- 4Artemis moon mission breaks record for distance from Earth
- 5The Latest: Fueling begins as NASA aims to send 1st crew to the moon in 53 years
- Find the Wonders of the Silk Street: Following the Antiquated Shipping lanes
- Experience Is standing by: 10 Pleasant Setting up camp Areas to
- Must-Sit in front of the Programs from Europe and the US
- Vote in favor of Your Number one kind of pie
- Former Israeli judge does not expect Netanyahu to be pardoned
- Venice’s newest marvel is a wild, acrobatic dolphin. His refusal to leave puts him in danger
- 'The Housemaid' movie with Sydney Sweeney and Amanda Seyfried premieres this month. What the stars have said about the psychological thriller.
- 'Crammed into a cell with vermin at New Year'
- Raw oysters linked to ongoing salmonella outbreak infecting 64 across 22 states: CDC
